EPCAT III - Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban and Aspirin to Aspirin Alone Following Total Hip and Knee Arthroplasty
EPCAT III - Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban and Aspirin to Aspirin Alone Following Total Hip and Knee Arthroplasty
EPCAT III - 全髋关节和膝关节置换术后利伐沙班联合阿司匹林与单用阿司匹林的长期静脉血栓栓塞预防比较
批准号：
400981
负责人：
Shivakumar Sudeep P
金额：
$326.58万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-03-01 至 2024-03-01
中文摘要
翻译
背景：腿部和肺部血栓是髋关节和膝关节置换术后常见的并发症。手术后要使用血液稀释剂来防止血栓形成，但这种稀释剂价格昂贵，而且可能导致出血。阿司匹林已被证明有效
英文摘要
Background: Blood clots in the legs and lungs are common complications following hip and knee replacement surgery. Blood thinners are given after these surgeries to prevent blood clots, but are expensive and can lead to bleeding. Aspirin has been shown t
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
